Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective

Anemia is common in patients with cancer or with chronic kidney disease (CKD). Although the introduction of erythropoiesis-stimulating agents (ESAs) has transformed the management of anemia, their use has been complicated by a number of factors including frequent guideline updates, safety concerns a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aapro, Matti, Gascón, Pere, Patel, Kashyap, Rodgers, George M., Fung, Selwyn, Arantes, Luiz H., Wish, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333861/
https://www.ncbi.nlm.nih.gov/pubmed/30687083
http://dx.doi.org/10.3389/fphar.2018.01498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333861/
https://www.ncbi.nlm.nih.gov/pubmed/30687083
http://dx.doi.org/10.3389/fphar.2018.01498

Ejemplares similares